Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: An open-label trial

Annals of Allergy, Asthma and Immunology

Volumn 108, Issue 1, 2012, Pages 49-53

  Riedl, Marc A ^a   Hurewitz, David S ^b   Levy, Robyn ^c   Busse, Paula J ^d   Fitts, David ^e   Kalfus, Ira ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Family Allergy and Asthma Center   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e ViroPharma Incorporated   (United States)

^f M2G Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; DANAZOL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRONCHITIS; CHILD; CONSTIPATION; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INJECTION SITE PAIN; INJECTION SITE RASH; JOINT SWELLING; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NANOFILTER; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHINOPHARYNGITIS; SINUSITIS; STREPTOCOCCAL PHARYNGITIS; TREATMENT OUTCOME; VITAL SIGN;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOEDEMAS, HEREDITARY; CHILD; CHILD, PRESCHOOL; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT INACTIVATING AGENTS; FEMALE; FILTRATION; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84355162811     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2011.10.017     Document Type: Article

References (21)

1. M. Cugno, A. Zanichelli, F. Foieni, S. Caccia, M. Cicardi C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress Trends Mol Med 15 2009 69 78
2. A.E. Davis III The pathophysiology of hereditary angioedema Clin Immunol 114 2005 3 9
3. V.H. Donaldson, R.R. Evans A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase Am J Med 35 1963 37 44
4. U.C. Nzeako, E. Frigas, W.J. Tremaine Hereditary angioedema: a broad review for clinicians Arch Intern Med 161 2001 2417 2429 (Pubitemid 33043115)
5. B.L. Zuraw Hereditary angioedema N Engl J Med 359 2008 1027 1036
6. K. Bork, K. Siedlecki, S. Bosch, R.E. Schopf, W. Kreuz Asphyxiation by laryngeal edema in patients with hereditary angioedema Mayo Clin Proc 75 2000 349 354 (Pubitemid 30187107)
7. K. Bork, S.E. Barnstedt Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema Arch Intern Med 161 2001 714 718 (Pubitemid 32200225)
8. T.J. Craig, R.J. Levy, R.L. Wasserman Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks J Allergy Clin Immunol 124 2009 801 808
9. H. Farkas, L. Jakab, G. Temesszentandrási Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy J Allergy Clin Immunol 120 2007 941 947 (Pubitemid 47531846)
10. A.T. Waytes, F.S. Rosen, M.M. Frank Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate N Engl J Med 334 1996 1630 1634 (Pubitemid 26192522)
11. B.L. Zuraw, P.J. Busse, M. White Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema N Engl J Med 363 2010 513 522
12. K. Bork, G. Meng, P. Staubach, J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784 (Pubitemid 43923905)
13. M. Levi, G. Choi, C. Picavet, C.E. Hack Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency J Allergy Clin Immunol 117 2006 904 908
14. A. Agostoni, M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 1992 206 215
15. M. Cicardi, L.C. Zingale, A. Zanichelli, D.L. Deliliers, S. Caccia The use of plasma-derived C1 inhibitor in the treatment of hereditary angioedema Expert Opin Pharmacother 8 2007 3173 3181
16. T.J. Craig, A.K. Bewtra, S.L. Bahna C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks: final results of the I.M.P.A.C.T.2 study Allergy 66 2011 1604 1611
17. M. Cicardi, R.J. Levy, D.L. McNeil Ecalantide for the treatment of acute attacks in hereditary angioedema N Engl J Med 363 2010 523 531
18. M. Cicardi, A. Banerji, F. Bracho Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med 363 2010 532 541
19. R.J. Levy, W.R. Lumry, D.L. McNeil EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema Ann Allergy Asthma Immunol 104 2010 523 529
20. T. Bowen, M. Cicardi, H. Farkas 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema Allergy Asthma Clin Immunol 6 2010 24
21. T. Burnouf, M. Radosevich Nanofiltration of plasma-derived biopharmaceutical products Haemophilia 9 2003 24 37 (Pubitemid 36511630)